JPY 707.0
(0.43%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.09 Billion JPY | -52.34% |
2022 | 3.44 Billion JPY | -31.53% |
2021 | 5.54 Billion JPY | 68.32% |
2020 | 2.34 Billion JPY | -36.61% |
2019 | -7.65 Billion JPY | 18.71% |
2018 | 3.88 Billion JPY | -37.7% |
2017 | 8.28 Billion JPY | 52.92% |
2016 | 5.43 Billion JPY | -15.79% |
2015 | 5.33 Billion JPY | -0.06% |
2014 | 4.99 Billion JPY | -18.1% |
2013 | 6.7 Billion JPY | 16.93% |
2012 | 6.5 Billion JPY | -4.32% |
2011 | 6.7 Billion JPY | -21.96% |
2010 | 5.41 Billion JPY | -15.46% |
2009 | 7.87 Billion JPY | 4.41% |
2008 | 7.05 Billion JPY | -24.11% |
2007 | 8.1 Billion JPY | 9.59% |
2006 | 7.29 Billion JPY | -7.19% |
2005 | 8.73 Billion JPY | -4.04% |
2004 | 6.78 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 2.05 Billion JPY | 399.55% |
2023 Q2 | 370 Million JPY | -81.11% |
2023 FY | - JPY | -52.34% |
2023 Q4 | -1.42 Billion JPY | -212.45% |
2023 Q3 | 1.26 Billion JPY | 242.97% |
2023 Q1 | 1.95 Billion JPY | 270.64% |
2022 Q4 | -1.14 Billion JPY | -285.16% |
2022 Q1 | 1.71 Billion JPY | 217.43% |
2022 Q2 | 1.88 Billion JPY | 10.34% |
2022 Q3 | 620 Million JPY | -67.16% |
2022 FY | - JPY | -31.53% |
2021 Q1 | 4.61 Billion JPY | 404.48% |
2021 FY | - JPY | 68.32% |
2021 Q2 | 1.78 Billion JPY | -61.37% |
2021 Q3 | 515 Million JPY | -71.12% |
2021 Q4 | -1.45 Billion JPY | -382.91% |
2020 Q2 | 492 Million JPY | -19.87% |
2020 Q1 | 614 Million JPY | 6.23% |
2020 FY | - JPY | -36.61% |
2020 Q4 | 915 Million JPY | -10.21% |
2020 Q3 | 1.01 Billion JPY | 107.11% |
2019 Q3 | 1.35 Billion JPY | 8.09% |
2019 Q2 | 1.24 Billion JPY | 17.28% |
2019 FY | - JPY | 18.71% |
2019 Q4 | 578 Million JPY | -57.19% |
2019 Q1 | 1.06 Billion JPY | 1257.61% |
2018 FY | - JPY | -37.7% |
2018 Q3 | 510 Million JPY | -44.81% |
2018 Q4 | -92 Million JPY | -118.04% |
2018 Q2 | 924 Million JPY | 11.73% |
2018 Q1 | 827 Million JPY | 250.36% |
2017 FY | - JPY | 52.92% |
2017 Q4 | -550 Million JPY | -149.33% |
2017 Q3 | 1.11 Billion JPY | -68.55% |
2017 Q2 | 3.54 Billion JPY | 221.11% |
2017 Q1 | 1.1 Billion JPY | 135.39% |
2016 Q1 | 418 Million JPY | 183.6% |
2016 FY | - JPY | -15.79% |
2016 Q3 | 554 Million JPY | -43.12% |
2016 Q4 | 469 Million JPY | -15.34% |
2016 Q2 | 974 Million JPY | 133.01% |
2015 Q3 | 1.27 Billion JPY | 3.82% |
2015 FY | - JPY | -0.06% |
2015 Q2 | 1.23 Billion JPY | 9.81% |
2015 Q1 | 1.12 Billion JPY | 339.61% |
2015 Q4 | -500 Million JPY | -139.12% |
2014 Q1 | 1.3 Billion JPY | 609.24% |
2014 FY | - JPY | -18.1% |
2014 Q4 | 255 Million JPY | -83.37% |
2014 Q3 | 1.53 Billion JPY | 146.46% |
2014 Q2 | 622 Million JPY | -52.34% |
2013 Q3 | 1.94 Billion JPY | 31.35% |
2013 Q4 | 184 Million JPY | -90.53% |
2013 FY | - JPY | 16.93% |
2013 Q1 | 2.34 Billion JPY | 460.38% |
2013 Q2 | 1.48 Billion JPY | -36.97% |
2012 Q2 | 761 Million JPY | -21.14% |
2012 Q4 | 419 Million JPY | -80.12% |
2012 Q3 | 2.1 Billion JPY | 177.0% |
2012 Q1 | 965 Million JPY | 176.22% |
2012 FY | - JPY | -4.32% |
2011 Q1 | 2.25 Billion JPY | -4.85% |
2011 Q2 | 2.18 Billion JPY | -3.06% |
2011 Q3 | 1.74 Billion JPY | -20.34% |
2011 Q4 | -1.26 Billion JPY | -172.63% |
2011 FY | - JPY | -21.96% |
2010 Q4 | 2.37 Billion JPY | -3.06% |
2010 FY | - JPY | -15.46% |
2010 Q1 | 2.33 Billion JPY | 16.48% |
2010 Q3 | 2.44 Billion JPY | 47.59% |
2010 Q2 | 1.65 Billion JPY | -29.12% |
2009 Q4 | 2 Billion JPY | -33.95% |
2009 Q3 | 3.04 Billion JPY | 19.5% |
2009 Q2 | 2.54 Billion JPY | -11.36% |
2009 Q1 | 2.87 Billion JPY | 30.93% |
2009 FY | - JPY | 4.41% |
2008 Q3 | 2.43 Billion JPY | 17.92% |
2008 Q4 | 2.19 Billion JPY | -9.98% |
2008 FY | - JPY | -24.11% |
2008 Q2 | 2.06 Billion JPY | 0.0% |
2007 FY | - JPY | 9.59% |
2006 FY | - JPY | -7.19% |
2005 FY | - JPY | -4.04% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | -159.411% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 63.26% |
Create Medic Co., Ltd. | 1.39 Billion JPY | -50.641% |
PHC Holdings Corporation | 39.08 Billion JPY | 94.638% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | -7.31% |
Rion Co., Ltd. | 4.37 Billion JPY | 52.11% |
Nihon Kohden Corporation | 23.44 Billion JPY | 91.06% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 94.215% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 83.083% |
Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 35.967% |
3-D Matrix, Ltd. | 2.09 Billion JPY | -0.191% |
CYBERDYNE Inc. | -2 Million JPY | 104900.0% |